Brief: Heartbeam Announces Strategic Shift To Accelerate Global Adoption Of Its Ambulatory ECG Signal Platform And Leadership Transition
24/06/2026 23:26
BRIEF-Heartbeam Announces Strategic Shift To Accelerate Global Adoption Of Its Ambulatory ECG Signal Platform And Leadership Transition June 24 (Reuters) - Heartbeam Inc BEAT.O:
HEARTBEAM ANNOUNCES STRATEGIC SHIFT TO ACCELERATE GLOBAL ADOPTION OF ITS AMBULATORY ECG SIGNAL PLATFORM AND LEADERSHIP TRANSITION
HEARTBEAM - TO LICENSE 3D ECG TECHNOLOGY TO PARTNERS, MOVES BEYOND DIRECT DEVICE SALES
HEARTBEAM - ADVANCING TOWARD HEART ATTACK DETECTION AS KEY PLATFORM EXPANSION
Source text: ID:nBw3fF04a
Further company coverage: BEAT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HeartBeam
See all newsBrief: Heartbeam Receives FDA Breakthrough Device Designation For Heart Attack Assessment
Brief: HeartBeam Will Not Build Large Commercial Organization For Arrhythmia Indication
Brief: Heartbeam, Inc. Enters Into At-The-Market Equity Offering Sales Agreement For Up To $25 Million In Common Stock
HeartBeam, Inc. reports results for the quarter ended June 30 - Earnings Summary
HeartBeam Q2 loss per share narrows; co lowers FY net operating cash outflow guidance